← Leaderboards
Emma Guttman
Icahn School Of Medicine At Mount Sinai
$8,500,791
Attributed
$8,855,049
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,855,049 · 6
By mechanism
U01$4,572,605 · 2
UM1$2,756,777 · 1
U19$817,150 · 2
R61$708,517 · 1
Top collaborators
- Dusan Bogunovic2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Silvia De Rubeis$5,011,415
- Keith Magnus Sigel$6,937,762
- Gregg W. Stone$348,111
- Nicole Dubois$4,896,461
- Joel Thomas Dudley$4,550,063
Others in their field
Top investigators on “Atopic Dermatitis”
- Donald Ym Leung · University Of Colorado Denver$67,663,761
- David Leung · National Jewish Health$31,859,607
- Samuel Arbes · Univ Of North Carolina Chapel Hill$30,600,034
- Richard L Gallo · University Of California, San Diego$20,144,691
- Gurjit K Khurana Hershey · Children'S Hospital Med Ctr (Cincinnati)$16,546,601
- Steven F Ziegler · Seattle Children'S Hospital$14,953,425
Research focus
Atopic DermatitisInflammationCytokinePathway InteractionsMolecularImmuneSkinResponseBiopsyAffectBiological MarkersAdultPhenotypeSeveritiesPathogenesisPsoriasisInflammatoryReportingBloodProteinsHyperplasiaImmunohistochemistryKeratinocyteImmune Targeting
Grant awards (20)
Dupilumab in the Treatment of Pediatric Alopecia Areata$1,319,400
U01 · FY2025 · AI · contact PI
Use of specific JAK inhibition on inflammatory skin and scalp diseases in Down syndrome$409,397
R61 · FY2025 · AR · contact PI
Role of Skin Barrier and Immune Alterations in Allergic Sensitization$266,625
U19 · FY2025 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2025 · AI · contact PI
Dupilumab in the Treatment of Pediatric Alopecia Areata$1,419,216
U01 · FY2024 · AI · contact PI
Use of specific JAK inhibition on inflammatory skin and scalp diseases in Down syndrome$299,120
R61 · FY2024 · AR · contact PI
Role of Skin Barrier and Immune Alterations in Allergic Sensitization$266,625
U19 · FY2024 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2024 · AI · contact PI
Role of Skin Barrier and Immune Alterations in Allergic Sensitization$283,900
U19 · FY2023 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2023 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2022 · AI · contact PI
Characterizing the Immune Response to COVID-19 Infection in Atopic Dermatitis$244,597
U01 · FY2021 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2021 · AI · contact PI
Characterizing the Immune Response to COVID-19 Infection in Atopic Dermatitis$244,936
U01 · FY2020 · AI · contact PI
Developing a Molecular Map of Atopic Dermatitis Across Ethnicity and Severity Subtypes.$224,076
U01 · FY2020 · AI · contact PI
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis$604,490
UM1 · FY2017 · AR · contact PI
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis$592,965
UM1 · FY2016 · AR · contact PI
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis$288,932
UM1 · FY2015 · AR · contact PI
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis$638,854
UM1 · FY2014 · AR · contact PI
A Study of ILV-94 (Anti-22 Antibody) Administered via IV in Atopic Dermatitis$631,536
UM1 · FY2013 · AR · contact PI